Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1005 clinical trials
featured
ER+/HER2- Breast Cancer

People with breast cancer are asked to participate in a research study being conducted by Montefiore Medical Center.  

  • 9 views
  • 27 Jan, 2020
  • 1 location
featured
HER2-negative advanced breast cancer

People with HER2 negative advanced breast cancer are asked to participate in a research study being conducted by Montefiore Medical Center.  

advanced breast cancer
HER2
  • 21 views
  • 02 Aug, 2019
  • 1 location
featured
A Randomized Phase II Trial of Tamoxifen Versus Z-Endoxifen HCl in Postmenopausal Women with Metastatic, Estrogen Receptor Positive, HER2 Negative Breast Cancer

A Randomized Phase II Trial of Tamoxifen Versus Z-Endoxifen HCl in Postmenopausal Women with Metastatic, Estrogen Receptor Positive, HER2 Negative Breast Cancer

erbb2
estrogen receptor
HER2
estrogen
breast cancer
  • 378 views
  • 23 Nov, 2020
  • 1 location
featured
A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for Node Positive HER2 Negative Breast Cancer: The ABC Trial (Alliance A011502)

A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for Node Positive HER2 Negative Breast Cancer: The ABC Trial (Alliance A011502)

erbb2
breast cancer
HER2
  • 560 views
  • 03 Dec, 2020
  • 1 location
featured
PHASE III RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIAL EVALUATING THE USE OF ADJUVANT ENDOCRINE THERAPY +/- ONE YEAR OF EVEROLIMUS IN PATIENTS WITH HIGH-RISK, HORMONE RECEPTOR-POSITIVE AND HER2/NEU NEGATIVE BREAST CANCER.

PHASE III RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIAL EVALUATING THE USE OF ADJUVANT ENDOCRINE THERAPY +/- ONE YEAR OF EVEROLIMUS IN PATIENTS WITH HIGH-RISK, HORMONE RECEPTOR-POSITIVE AND HER2

endocrine therapy
erbb2
hormone therapy
HER2
breast cancer
  • 220 views
  • 24 Nov, 2020
  • 1 location
featured
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel with or without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer

A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel with or without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer

doxorubicin
carboplatin
cyclophosphamide
invasive breast cancer
paclitaxel
  • 66 views
  • 03 Dec, 2020
  • 1 location
featured
Advanced Breast Cancer with Visceral Metastases

People with advanced breast cancer are asked to participate in a research study being conducted by White Plains Hospital.  

advanced breast cancer
  • 22 views
  • 02 Aug, 2019
  • 1 location
featured
HER2 Negative Advanced Breast Cancer

People with HER2 negative advanced breast cancer are asked to participate in a research study being conducted by Queens Hospital Center.  

cancer
advanced breast cancer
HER2
  • 27 views
  • 28 Oct, 2019
  • 1 location
featured
CheckMate 7A8 - ER+/HER2- Breast Cancer

People with breast cancer are asked to participate in a research study being conducted by Montefiore Medical Center.  

  • 4 views
  • 23 Nov, 2020
  • 1 location
featured
Receptor 2 negative (HR+/HER2-) breast cancer – Astra Zeneca

People with breast cancer are asked to participate in a research study being conducted by Monter Cancer Center.

  • 0 views
  • 22 Jul, 2020
  • 1 location